Avance Clinical has more than two decades of deep clinical experience delivering high-quality trial data that is accepted by all of the major regulatory agencies around the globe.
Approximately 96% of the work is supporting small to medium-sized biotechnology companies executing Phase 1 and Phase 2 trials. Avance Clinical’s client base currently extends across APAC, North America, Canada, EU, and New Zealand.